An increasing trend of isolates with simultaneous RTA and DSC will likely impede the introduction of the currently WHO-recommended dual therapy in China.
← all excerpts
Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
1
—
—